Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Phase II trial begins with rPAF-AH in pancreatitis

March 17, 1998

Intercardia to license IBD drug

March 13, 1998

Novel gastrointestinal agents in early development at Dainippon

March 12, 1998

New cisapride formulation introduced in U.K.

March 9, 1998

Astra develops new gastric antisecretory agents

March 6, 1998

Triangle Pharmaceuticals obtains license to L-FMAU for HBV treatment

March 5, 1998

NIH will license technology that may lead to new HCV vaccines

March 3, 1998

Profile of a motilide: Abbott's ABT-229

March 2, 1998

First approvals for Zadaxin outside Asia

March 2, 1998

Priority review status granted for Avakine

Feb. 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...